TipRanks on MSN
Contineum Therapeutics Reports Phase 2 Trial Results
Contineum Therapeutics, Inc. Class A ( ($CTNM) ) has shared an update. On November 20, 2025, Contineum Therapeutics reported topline data from its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback